Fenylefrine Unimedic

Fenylefrine Unimedic is a phenylephrine-based medication used for intravenous administration. It is commonly associated with cardiovascular support and blood pressure management. This product is manufactured by Unimedic Pharma AB in the EU.

Fenylefrine Unimedic, containing phenylephrine, is primarily used to support cardiovascular function and manage blood pressure. It is often administered intravenously to address conditions related to low blood pressure or circulatory issues. Phenylephrine is known for its vasoconstrictive properties, which can help in maintaining adequate blood flow and pressure.

When administered intravenously, Fenylefrine Unimedic may cause an increase in blood pressure due to its vasoconstrictive effects. Common effects can include a temporary rise in heart rate and changes in blood flow. These effects are typically monitored closely by healthcare professionals to ensure safety and efficacy.

Fenylefrine Unimedic should be handled with care and administered under the supervision of a healthcare professional. It is important to follow proper dosage guidelines and monitor for any adverse reactions. Patients with certain cardiovascular conditions should use this medication with caution.

Fenylefrine Unimedic may interact with other medications, particularly those that affect blood pressure or heart rate. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain CYP inhibitors may also influence the effects of phenylephrine.